Management of Residual Risk After Statin Therapy

Atherosclerosis - Netherlands
doi 10.1016/j.atherosclerosis.2015.12.018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Letter From Egom Regarding Article, "High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy"

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

Beyond LDL-Cholesterol: The Role of Low HDL-Cholesterol and Elevated TG in Residual Cardiovascular Risk Remaining After Statin Therapy

Journal of Managed Care Pharmacy
2008English

Complications of Statin Therapy and Their Management

Journal of Evolution of Medical and Dental Sciences
2016English

Blood Lipid Levels, Statin Therapy and the Risk of Intracerebral Hemorrhage

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2016English

Statin Use Recommendation in Cardiovascular Risk Management Is Controversial

American Journal of Medicine
Medicine
2019English

Interleukin-6 and Statin Therapy: Potential Role in the Management of COPD

Respiratory Research
PulmonaryRespiratory Medicine
2013English

Effect of Early Statin Therapy on Risk of Atrial Fibrillation After Coronary Artery Bypass Grafting With or Without Concomitant Valve Surgery

American Journal of Cardiology
Cardiovascular MedicineCardiology
2011English

Overcoming Challenges With Statin Therapy

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2016English

Statin Therapy for Skeletal Dysplasia

Nature Reviews Endocrinology
EndocrinologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy